Guiling Li
Impact in
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 19
- Cancer Immunotherapy and Biomarkers 15
- Cancer Cells and Metastasis 3
- CAR-T cell therapy research 3
-
- Endometrial and Cervical Cancer Treatments 7
- Co-authors
- Yumeng Wang (8 shared papers)Congjian Xu (4 shared papers)Wei Jiang (1 shared paper)Congjian Xu (9 shared papers)Chong Lu (5 shared papers)Meng Zhang (3 shared papers)Jing Peng (5 shared papers)Meng Zhang (5 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Journal of Ethnopharmacology (3 papers)Frontiers in Immunology (2 papers)Gynecologic Oncology (2 papers)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Guiling Li
37 papers receiving 514 citations
Peers
Comparison fields: 5 of 77
- Obstetrics and Gynecology 107
- Reproductive Medicine 103
- Oncology 190
- Drug Discovery 1
- Immunology 122
Countries citing papers authored by Guiling Li
This map shows the geographic impact of Guiling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiling Li more than expected).
Fields of papers citing papers by Guiling Li
This network shows the impact of papers produced by Guiling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiling Li. The network helps show where Guiling Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Guiling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 68 | |
| 2 | 2022 | 44 | |
| 3 | 2022 | 44 | |
| 4 | 2010 | 42 | |
| 5 | 2019 | 39 | |
| 6 | 2010 | 34 | |
| 7 | 2020 | 31 | |
| 8 | 2021 | 27 | |
| 9 | 2022 | 24 | |
| 10 | 2019 | 19 | |
| 11 | 2020 | 17 | |
| 12 | 2016 | 14 | |
| 13 | 2019 | 14 | |
| 14 | 2021 | 13 | |
| 15 | 2023 | 10 | |
| 16 | 2022 | 10 | |
| 17 | 2023 | 8 | |
| 18 | 2017 | 8 | |
| 19 | 2022 | 8 | |
| 20 | 2022 | 7 |
About Guiling Li
Guiling Li is a scholar working on Oncology, Obstetrics and Gynecology, Reproductive Medicine, Immunology and Molecular Biology, having authored 38 papers that have together received 523 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (15 papers), Endometrial and Cervical Cancer Treatments (7 papers), Ovarian cancer diagnosis and treatment (7 papers), Immunotherapy and Immune Responses (4 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer Cells and Metastasis (3 papers), Immune Cell Function and Interaction (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Obstetrics and Gynecology (107 citations), Reproductive Medicine (103 citations), Oncology (190 citations), Drug Discovery (1 citation) and Immunology (122 citations). Guiling Li has collaborated with scholars based in China, United States and India. Frequent co-authors include Yumeng Wang, Congjian Xu, Wei Jiang, Congjian Xu, Wei Jiang, Chong Lu, Meng Zhang, Jing Peng, Meng Zhang and Songhua Chen. Their work appears in journals such as Journal of Clinical Oncology, Journal of Ethnopharmacology, Frontiers in Immunology, Gynecologic Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.